What is Risperdal?
Risperdal is an anti-psychotic drug that was first approved by the FDA in 1993 to treat schizophrenia in adults.
The FDA later expanded approval of the drug to treat irritability in children and adolescents that were directly related to autism.
It has since also been approved to treat acute mania and bipolar disorders in younger patients.
Physicians have also commonly prescribed Risperdal off-label to treat other disorders among young patients, including attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD).
Risperdal Lawsuits Continue to Be Filed
As more young patients began taking Risperdal, concerns began to grow about the drug’s potential side effects, which for some patients can persist long after the drug is discontinued.
Risperdal lawsuits are being brought by males who claim that their prescription caused them to develop gynecomastia – enlarged breasts in men.
Since many of these young men are still not of legal age, the timing of the filing of these Risperdal lawsuits are not as strict and we anticipate that more of these lawsuits will continue to move through the courts.
Risperdal Side Effects
- Increased mortality among elderly patients
- Abnormal breast growth in young men, known as gynecomastia
- Movement disorders
- Neuroleptic malignant syndrome (NMS), a relatively rare but potentially fatal neurological condition
- Parkinsonism, including tremors and difficulty with movement and balance
While gynecomastia is not usually medically dangerous for young men, the psychological effects can be devastating.
A study published in the Plastic Reconstructive Surgery journal in 2013 concluded that gynecomastia has a significant psychosocial impact on adolescent patients that affects their self-esteem, mental health, and ability to function socially.